Use of agomelatine, to obtain a drug to treat Smith Magenis syndrome, major depression, seasonal depression, sleep disorder, cardiovascular disease, digestive system disorder, insomnia, shiftlag, appetite disorders and obesity

摘要

The use (I) of agomelatine or its hydrate, crystalline form and acid or base addition salts obtain a drug to treat Smith's Magenis syndromes and be also claimed. Independent claims include a kind of composition, comprising (I) optionally with excipient. Activity: antidepressants; Hypnosis; It is cardiovascular common; Anoretics. The mechanism of action: 5-Hydroxytryptamine-2C antagonists; Melatonin energy receptor stimulating agent.